---
title: "Fluidx Medical announces first patient treated in prospective trial"
date: "2024-11-27T14:57:08.000Z"
publishedDate: "27 novembre 2024"
summary: "Fluidx Medical has announced that the first patient has been treated in the GPX investigational device exception (IDE) prospective multinational clinical trial. The GPX embolic device was successfully used in a portal vein embolization procedure in preparation for hepatic resection."
importance: ""
sourceUrl: "https://interventionalnews.com/fluidx-medical-announces-first-patient-treated-in-prospective-trial/"
tags: ["France", "Actualité", "Interventional News — Latest"]
permalink: "/papers/2024-11-27-fluidx-medical-announces-first-patient-treated-in-prospective-trial"
imageUrl: "http://interventionalnews.com/wp-content/uploads/sites/13/2024/11/GPX-Trial-1st-Patient-Final.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://interventionalnews.com/fluidx-medical-announces-first-patient-treated-in-prospective-trial/"
---

![Fluidx Medical announces first patient treated in prospective trial](http://interventionalnews.com/wp-content/uploads/sites/13/2024/11/GPX-Trial-1st-Patient-Final.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://interventionalnews.com/fluidx-medical-announces-first-patient-treated-in-prospective-trial/*

## L’essentiel

Fluidx Medical has announced that the first patient has been treated in the GPX investigational device exception (IDE) prospective multinational clinical trial. The GPX embolic device was successfully used in a portal vein embolization procedure in preparation for hepatic resection.

## Lien source

https://interventionalnews.com/fluidx-medical-announces-first-patient-treated-in-prospective-trial/
